Antiviral benzyl-amine phosphodiamide compounds
US11123355B2 · kind B2 · utility
0Cited by
14References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 19, 2017 |
| Grant date | Sep 21, 2021 |
| Priority date | — |
| Expiry date | Jun 13, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula I: and their pharmaceutically acceptable salts are useful for the inhibition of HIV reverse transcriptase. The compounds may also be useful for the prophylaxis or treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antiviral agents, immunomodulators, antibiotics or vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.